used for treatment of ischemic infarction as injection
Cerebrolysin is a so-called neurotrophic agent rather than an anti-infarction drug. It is believed to act as endogenous neurotrophic factors (NGF etc.), thus exhibiting neuroprotective effect. There are some studies demonstrating improved outcomes in ischemic stroke patients. The product is available in a limited number of countries.
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Posted 17 Dec 2009 • 2 answers
Posted 19 Oct 2011 • 2 answers
Posted 14 Mar 2012 • 1 answer
Posted 17 May 2012 • 2 answers
Posted 1 Jul 2013 • 4 answers